CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...
Yet the same day, CVS filed its annual report to shareholders with a new paragraph about “uncertainty” around changing health ...
Before serving as interim president at Caremark, DeVaney led sales and account management as president of employer and health ...
1d
Barchart on MSNThis Dividend Stock Is Up 45% in 2025. Is It Too Late to Buy Shares Now?Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.
3don MSN
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...
In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2025.
Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS ...
Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted ...
CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report to Prem Shah ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results